Lung cancer patients may benefit from delayed chemotherapy after

A new Yale study suggests that patients with a common form of lung cancer may still benefit from delayed chemotherapy started up to four months after surgery, according to the researchers.

Two new cancer pills show 'unprecedented' results in boosting survival rates and preventing recurrence

AEGEAN Shows Benefit with the Addition of Perioperative Durvalumab to Neoadjuvant Chemotherapy in Resectable NSCLC - (ILCN/WCLC)

Lung cancer: Delayed chemotherapy after surgery may still be beneficial

Local Therapy Extends Use of Targeted Drugs in Oligoprogressive Lung Cancer

New Treatment Minimizes Side Effects of Chemotherapy for Lung Cancer Patients

Delay to surgical treatment in lung cancer patients and its impact on survival in a video-assisted thoracoscopic lobectomy cohort

Signal pathways and precision therapy of small-cell lung cancer

Cancers, Free Full-Text

What is the Clinical Impact of COVID-19 on Cancer Patients?

How did Covid impact healthcare and cancer patients?

Small cell lung cancer: chest radiotherapy 'prolongs survival, reduces recurrence